The coronavirus is upending many of the hallmarks of the American university experience. This may be only the beginning of what is to come.
US: Harvard gives students 5 days to evacuate over coronavirus fears—here’s what students have to say
US: Blade contributor wins asylum case, released from ICE custody
Canada: Federal Liberals introduce bill aimed at cracking down on conversion therapy
South Africa: Community-based HIV treatment superior to clinic-based care for men
New high-cost HIV prevention drug: 'Better' isn't worth it
A newly approved drug for HIV pre-exposure prophylaxis (PrEP) is unlikely to confer any discernible health benefit over generic alternatives and may undermine efforts to expand access to HIV prevention for the nation's most vulnerable populations, according to a new study appearing today in the Annals of Internal Medicine.